JDURX | MMUKX | JDURX / MMUKX | |
Total Expense Ratio | 1.11 | 0.66 | 168% |
Annual Report Gross Expense Ratio | 1.36 | 0.67 | 203% |
Fund Existence | 19 years | 13 years | - |
Gain YTD | 2.398 | 4.320 | 55% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.21B | 2.49B | 129% |
Annual Yield % from dividends | 1.55 | 2.39 | 65% |
Returns for 1 year | 5.77 | 8.07 | 71% |
Returns for 3 years | 2.21 | 2.98 | 74% |
Returns for 5 years | 17.11 | 28.80 | 59% |
Returns for 10 years | 11.07 | 28.79 | 38% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MIQBX | 11.34 | 0.08 | +0.71% |
Morgan Stanley Inst International Eq A | |||
TIDDX | 67.51 | 0.47 | +0.70% |
T. Rowe Price International Discovery I | |||
MRJIX | 10.69 | 0.06 | +0.56% |
Morgan Stanley Multi-Asset Real Return I | |||
NWAVX | 14.49 | N/A | N/A |
Nationwide GQG US Quality Eq R6 | |||
MVISX | 38.55 | -0.29 | -0.75% |
Patient Opportunity IS |